10

Feb

2017

CVS Caremark Part D Services: 2016-2017 Performance Network Program Overview and Comparison

Please see the attached PDF with important information regarding CVS Caremark Performance Network Program: 2016-2017 Program Overview and Comparison.

7

Oct

2016

Mirixa: Humana Star Ratings Program Re-launched

Humana Star Ratings Program Re-launched!

Up to $40 for Achieving Adherence Goals

 

Mirixa will soon re-launch an updated Humana Star Ratings Program. The goal of this program is to improve patients' adherence to target medications, by ensuring that patients have a sufficient quantity of each medication to achieve a Proportion of Days Covered ("PDC") greater than 80%, and by counseling patients on the importance of adherence.

 

Cases will be presented with "General Adherence Counseling Alerts," and/or "Conversion Counseling Alerts." The Conversion Counseling Alerts encourage pharmacists to fill a patient's prescription with a 90-day supply of medication rather than a 30-day supply, as a means of improving the patient's adherence. 

 

Mirixa will pay the pharmacy up to $40.00 per alert, payable in one or two installments per the terms below. To receive payment, pharmacists are required to resolve each alert by:

9

Jun

2016

Mirixa: Aetna 30-90 Day Conversion Program has Returned - $25 Payment for Patient Acceptance of a Conversion


Aetna 30-90 Day Conversion Program has Returned


$25 payment for Patient Acceptance of a Conversion


 The Aetna 30-90 Day Conversion Program will relaunch soon with the continuing goal of converting patients from a 30-day fill schedule to a 90-day fill schedule to promote patient adherence.   Cases will begin to arrive in pharmacy queues in mid-June, 2016.

5

May

2016

Mirixa News: New Mirixa Programs Launching Next Week - May 9, 2016

CVSC Performance Network Drug Therapy Program and the SSI Performance Network Drug Therapy Program will launch this coming Monday, May 9th. These new cases will focus on potential gaps of omission issues for eligible CVS/Caremark and SSI plan participants who are your patients. For example, the patient appears to have diabetes, but does not appear to be on a statin therapy to reduce the risk of atherosclerotic cardiovascular disease (ASCVD). I will not be able to share a case forecast/potential report with you for these programs.

28

Apr

2016

Important Mirixa Notification - Additional CVS Caremark MTM Cases Released

Important Mirixa Notification

Additional CVS Caremark MTM Program Cases (CMR cases) have finished releasing to your pharmacy on the MirixaPro platform. Since Mirixa was unable to provide a forecast/case potential report for this release, they have gone ahead and added a one week extension to assist your pharmacy with case completion. The new due date for these cases will be June 2nd.

1234 Last